ID   GCKR_HUMAN              Reviewed;         625 AA.
AC   Q14397; A1L4C2; B4DPQ2; Q53RY6; Q99522;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   05-APR-2011, sequence version 6.
DT   03-AUG-2022, entry version 168.
DE   RecName: Full=Glucokinase regulatory protein {ECO:0000303|PubMed:8589523};
DE            Short=GKRP {ECO:0000303|PubMed:23621087};
DE            Short=Glucokinase regulator {ECO:0000303|PubMed:9570959};
GN   Name=GCKR {ECO:0000303|PubMed:8589523, ECO:0000312|HGNC:HGNC:4196};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RC   TISSUE=Hepatoblastoma;
RX   PubMed=8589523; DOI=10.1007/bf00356171;
RA   Warner J.P., Leek J.P., Intody S., Markham A.F., Bonthron D.T.;
RT   "Human glucokinase regulatory protein (GCKR): cDNA and genomic cloning,
RT   complete primary structure, and chromosomal localization.";
RL   Mamm. Genome 6:532-536(1995).
RN   [2]
RP   PARTIAL NUCLEOTIDE SEQUENCE [GENOMIC DNA], SEQUENCE REVISION TO 393 AND
RP   560, AND TISSUE SPECIFICITY.
RX   PubMed=9570959; DOI=10.1006/geno.1997.5195;
RA   Hayward B.E., Dunlop N., Intody S., Leek J.P., Markham A.F., Warner J.P.,
RA   Bonthron D.T.;
RT   "Organization of the human glucokinase regulator gene GCKR.";
RL   Genomics 49:137-142(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS GLY-77; SER-256; LEU-446
RP   AND GLN-540.
RG   NIEHS SNPs program;
RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Liver;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT LEU-446.
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=10456334; DOI=10.1016/s0014-5793(99)00971-0;
RA   de la Iglesia N., Veiga-da-Cunha M., Van Schaftingen E., Guinovart J.J.,
RA   Ferrer J.C.;
RT   "Glucokinase regulatory protein is essential for the proper subcellular
RT   localisation of liver glucokinase.";
RL   FEBS Lett. 456:332-338(1999).
RN   [8]
RP   INVOLVEMENT IN FGQTL5, VARIANT LEU-446, AND ASSOCIATION WITH LOWER RISK FOR
RP   DIABETES TYPE 2.
RX   PubMed=18556336; DOI=10.2337/db07-1807;
RA   Vaxillaire M., Cavalcanti-Proenca C., Dechaume A., Tichet J., Marre M.,
RA   Balkau B., Froguel P.;
RT   "The common P446L polymorphism in GCKR inversely modulates fasting glucose
RT   and triglyceride levels and reduces type 2 diabetes risk in the DESIR
RT   prospective general French population.";
RL   Diabetes 57:2253-2257(2008).
RN   [9]
RP   TISSUE SPECIFICITY, AND CHARACTERIZATION OF VARIANT LEU-446.
RX   PubMed=19643913; DOI=10.1093/hmg/ddp357;
RA   Beer N.L., Tribble N.D., McCulloch L.J., Roos C., Johnson P.R.,
RA   Orho-Melander M., Gloyn A.L.;
RT   "The P446L variant in GCKR associated with fasting plasma glucose and
RT   triglyceride levels exerts its effect through increased glucokinase
RT   activity in liver.";
RL   Hum. Mol. Genet. 18:4081-4088(2009).
RN   [10]
RP   FUNCTION, INTERACTION WITH GCK, AND MUTAGENESIS OF ASP-413 AND
RP   463-LEU--PHE-465.
RX   PubMed=23733961; DOI=10.1073/pnas.1300457110;
RA   Choi J.M., Seo M.H., Kyeong H.H., Kim E., Kim H.S.;
RT   "Molecular basis for the role of glucokinase regulatory protein as the
RT   allosteric switch for glucokinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:10171-10176(2013).
RN   [11] {ECO:0007744|PDB:4BB9, ECO:0007744|PDB:4BBA}
RP   X-RAY CRYSTALLOGRAPHY (1.47 ANGSTROMS) IN COMPLEX WITH
RP   BETA-D-FRUCTOSE-1-PHOSPHATE, FUNCTION, INTERACTION WITH GCK, AND
RP   MUTAGENESIS OF 326-LYS-LYS-327 AND 450-LYS-LYS-451.
RX   PubMed=23621087; DOI=10.1021/bi4000782;
RA   Pautsch A., Stadler N., Lohle A., Rist W., Berg A., Glocker L., Nar H.,
RA   Reinert D., Lenter M., Heckel A., Schnapp G., Kauschke S.G.;
RT   "Crystal structure of glucokinase regulatory protein.";
RL   Biochemistry 52:3523-3531(2013).
RN   [12]
RP   VARIANT LEU-446, INVOLVEMENT IN FGQTL5, AND ASSOCIATION WITH HIGH PLASMA
RP   TRIGLYCERIDE LEVELS.
RX   PubMed=18678614; DOI=10.2337/db08-0516;
RA   Orho-Melander M., Melander O., Guiducci C., Perez-Martinez P., Corella D.,
RA   Roos C., Tewhey R., Rieder M.J., Hall J., Abecasis G., Tai E.S., Welch C.,
RA   Arnett D.K., Lyssenko V., Lindholm E., Saxena R., de Bakker P.I., Burtt N.,
RA   Voight B.F., Hirschhorn J.N., Tucker K.L., Hedner T., Tuomi T., Isomaa B.,
RA   Eriksson K.F., Taskinen M.R., Wahlstrand B., Hughes T.E., Parnell L.D.,
RA   Lai C.Q., Berglund G., Peltonen L., Vartiainen E., Jousilahti P.,
RA   Havulinna A.S., Salomaa V., Nilsson P., Groop L., Altshuler D.,
RA   Ordovas J.M., Kathiresan S.;
RT   "Common missense variant in the glucokinase regulatory protein gene is
RT   associated with increased plasma triglyceride and C-reactive protein but
RT   lower fasting glucose concentrations.";
RL   Diabetes 57:3112-3121(2008).
CC   -!- FUNCTION: Regulates glucokinase (GCK) by forming an inactive complex
CC       with this enzyme (PubMed:23621087, PubMed:23733961). Acts by promoting
CC       GCK recruitment to the nucleus, possibly to provide a reserve of GCK
CC       that can be quickly released in the cytoplasm after a meal
CC       (PubMed:10456334). The affinity of GCKR for GCK is modulated by
CC       fructose metabolites: GCKR with bound fructose 6-phosphate has
CC       increased affinity for GCK, while GCKR with bound fructose 1-phosphate
CC       has strongly decreased affinity for GCK and does not inhibit GCK
CC       activity (PubMed:23621087, PubMed:23733961).
CC       {ECO:0000269|PubMed:10456334, ECO:0000269|PubMed:23621087,
CC       ECO:0000269|PubMed:23733961}.
CC   -!- SUBUNIT: Interacts (fructose 6-phosphate bound form) with GCK.
CC       {ECO:0000269|PubMed:10456334, ECO:0000269|PubMed:23621087,
CC       ECO:0000269|PubMed:23733961}.
CC   -!- INTERACTION:
CC       Q14397; P35557: GCK; NbExp=5; IntAct=EBI-709948, EBI-709928;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10456334}. Nucleus
CC       {ECO:0000269|PubMed:10456334}. Mitochondrion
CC       {ECO:0000250|UniProtKB:Q07071}. Note=Under low glucose concentrations,
CC       GCKR associates with GCK and the inactive complex is recruited to the
CC       hepatocyte nucleus. {ECO:0000269|PubMed:10456334}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q14397-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q14397-2; Sequence=VSP_054853, VSP_054854;
CC   -!- TISSUE SPECIFICITY: Found in liver and pancreas. Not detected in
CC       muscle, brain, heart, thymus, intestine, uterus, adipose tissue,
CC       kidney, adrenal, lung or spleen. {ECO:0000269|PubMed:19643913,
CC       ECO:0000269|PubMed:9570959}.
CC   -!- DOMAIN: Fructose 1-phosphate and fructose 6-phosphate compete for the
CC       same binding site. {ECO:0000269|PubMed:23621087}.
CC   -!- POLYMORPHISM: Genetic variations in GCKR define the fasting plasma
CC       glucose levels quantitative trait locus 5 (FGQTL5) [MIM:613463]
CC       (PubMed:18556336, PubMed:18678614). The normal fasting plasma glucose
CC       level is defined as less than 100 mg glucose per deciliter plasma (5.55
CC       mmol per liter). Higher fasting plasma glucose levels predict type 2
CC       diabetes in young adults and increases the risk of mortality
CC       (PubMed:18556336, PubMed:18678614). {ECO:0000269|PubMed:18556336,
CC       ECO:0000269|PubMed:18678614}.
CC   -!- SIMILARITY: Belongs to the GCKR family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/gckr/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z48475; CAA88367.1; -; mRNA.
DR   EMBL; Y09593; CAA70779.2; -; Genomic_DNA.
DR   EMBL; Y09592; CAB61828.1; -; Genomic_DNA.
DR   EMBL; AY320034; AAP72013.1; -; Genomic_DNA.
DR   EMBL; AK298448; BAG60664.1; -; mRNA.
DR   EMBL; AC074117; AAY14850.1; -; Genomic_DNA.
DR   EMBL; BC130481; AAI30482.1; -; mRNA.
DR   EMBL; BC130483; AAI30484.1; -; mRNA.
DR   CCDS; CCDS1757.1; -. [Q14397-1]
DR   PIR; S52485; S52485.
DR   RefSeq; NP_001477.2; NM_001486.3.
DR   PDB; 4BB9; X-ray; 1.47 A; A=1-625.
DR   PDB; 4BBA; X-ray; 1.92 A; A=1-625.
DR   PDB; 4LY9; X-ray; 2.35 A; A/B=1-625.
DR   PDB; 4MQU; X-ray; 2.22 A; A/B=1-625.
DR   PDB; 4MRO; X-ray; 2.20 A; A/B=1-625.
DR   PDB; 4MSU; X-ray; 2.50 A; A/B=1-625.
DR   PDB; 4OHK; X-ray; 2.80 A; A/B=1-625.
DR   PDB; 4OHM; X-ray; 2.40 A; A/B=1-625.
DR   PDB; 4OHO; X-ray; 2.58 A; A/B=1-625.
DR   PDB; 4OHP; X-ray; 2.40 A; A/B=1-625.
DR   PDB; 4OLH; X-ray; 2.40 A; A/B=1-625.
DR   PDB; 4OP1; X-ray; 2.39 A; A/B=1-625.
DR   PDB; 4OP2; X-ray; 2.24 A; A/B=1-625.
DR   PDB; 4OP3; X-ray; 2.82 A; A/B=1-625.
DR   PDB; 4PX2; X-ray; 2.15 A; A/B=1-625.
DR   PDB; 4PX3; X-ray; 2.43 A; A/B=1-625.
DR   PDB; 4PX5; X-ray; 2.20 A; A/B=1-625.
DR   PDB; 4PXS; X-ray; 2.60 A; A/B=1-625.
DR   PDBsum; 4BB9; -.
DR   PDBsum; 4BBA; -.
DR   PDBsum; 4LY9; -.
DR   PDBsum; 4MQU; -.
DR   PDBsum; 4MRO; -.
DR   PDBsum; 4MSU; -.
DR   PDBsum; 4OHK; -.
DR   PDBsum; 4OHM; -.
DR   PDBsum; 4OHO; -.
DR   PDBsum; 4OHP; -.
DR   PDBsum; 4OLH; -.
DR   PDBsum; 4OP1; -.
DR   PDBsum; 4OP2; -.
DR   PDBsum; 4OP3; -.
DR   PDBsum; 4PX2; -.
DR   PDBsum; 4PX3; -.
DR   PDBsum; 4PX5; -.
DR   PDBsum; 4PXS; -.
DR   AlphaFoldDB; Q14397; -.
DR   SMR; Q14397; -.
DR   BioGRID; 108916; 7.
DR   IntAct; Q14397; 2.
DR   STRING; 9606.ENSP00000264717; -.
DR   BindingDB; Q14397; -.
DR   ChEMBL; CHEMBL1075152; -.
DR   iPTMnet; Q14397; -.
DR   PhosphoSitePlus; Q14397; -.
DR   BioMuta; GCKR; -.
DR   DMDM; 327478611; -.
DR   jPOST; Q14397; -.
DR   MassIVE; Q14397; -.
DR   PaxDb; Q14397; -.
DR   PeptideAtlas; Q14397; -.
DR   PRIDE; Q14397; -.
DR   ProteomicsDB; 4803; -.
DR   ProteomicsDB; 59979; -. [Q14397-1]
DR   DNASU; 2646; -.
DR   Ensembl; ENST00000417872.5; ENSP00000398303.1; ENSG00000084734.9. [Q14397-2]
DR   GeneID; 2646; -.
DR   KEGG; hsa:2646; -.
DR   UCSC; uc002rky.4; human. [Q14397-1]
DR   CTD; 2646; -.
DR   DisGeNET; 2646; -.
DR   GeneCards; GCKR; -.
DR   HGNC; HGNC:4196; GCKR.
DR   MalaCards; GCKR; -.
DR   MIM; 600842; gene.
DR   MIM; 613463; phenotype.
DR   neXtProt; NX_Q14397; -.
DR   OpenTargets; ENSG00000084734; -.
DR   PharmGKB; PA28611; -.
DR   VEuPathDB; HostDB:ENSG00000084734; -.
DR   eggNOG; ENOG502QS2J; Eukaryota.
DR   GeneTree; ENSGT00390000005345; -.
DR   HOGENOM; CLU_1739896_0_0_1; -.
DR   InParanoid; Q14397; -.
DR   OrthoDB; 858819at2759; -.
DR   PhylomeDB; Q14397; -.
DR   TreeFam; TF329177; -.
DR   PathwayCommons; Q14397; -.
DR   Reactome; R-HSA-170822; Regulation of Glucokinase by Glucokinase Regulatory Protein.
DR   Reactome; R-HSA-5619107; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC).
DR   SignaLink; Q14397; -.
DR   BioGRID-ORCS; 2646; 9 hits in 1079 CRISPR screens.
DR   GenomeRNAi; 2646; -.
DR   Pharos; Q14397; Tchem.
DR   PRO; PR:Q14397; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q14397; protein.
DR   Bgee; ENSG00000084734; Expressed in right lobe of liver and 96 other tissues.
DR   ExpressionAtlas; Q14397; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005739; C:mitochondrion; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; ISS:UniProtKB.
DR   GO; GO:0030246; F:carbohydrate binding; IBA:GO_Central.
DR   GO; GO:0019899; F:enzyme binding; IBA:GO_Central.
DR   GO; GO:0004857; F:enzyme inhibitor activity; IBA:GO_Central.
DR   GO; GO:0070095; F:fructose-6-phosphate binding; IDA:UniProtKB.
DR   GO; GO:1901135; P:carbohydrate derivative metabolic process; IEA:InterPro.
DR   GO; GO:0005975; P:carbohydrate metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0042593; P:glucose homeostasis; IBA:GO_Central.
DR   GO; GO:0033132; P:negative regulation of glucokinase activity; IDA:UniProtKB.
DR   GO; GO:0006606; P:protein import into nucleus; ISS:BHF-UCL.
DR   GO; GO:0009750; P:response to fructose; IDA:BHF-UCL.
DR   GO; GO:0070328; P:triglyceride homeostasis; IMP:BHF-UCL.
DR   GO; GO:0046415; P:urate metabolic process; IMP:BHF-UCL.
DR   InterPro; IPR005486; Glucokinase_regulatory_CS.
DR   InterPro; IPR040190; MURQ/GCKR.
DR   InterPro; IPR001347; SIS_dom.
DR   InterPro; IPR046348; SIS_dom_sf.
DR   PANTHER; PTHR10088; PTHR10088; 2.
DR   SUPFAM; SSF53697; SSF53697; 2.
DR   PROSITE; PS01272; GCKR; 1.
DR   PROSITE; PS51464; SIS; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Carbohydrate metabolism; Cytoplasm;
KW   Mitochondrion; Nucleus; Reference proteome; Repeat.
FT   CHAIN           1..625
FT                   /note="Glucokinase regulatory protein"
FT                   /id="PRO_0000214826"
FT   DOMAIN          90..286
FT                   /note="SIS 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00797"
FT   DOMAIN          320..499
FT                   /note="SIS 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00797"
FT   REGION          199..200
FT                   /note="Important for interaction with GCK"
FT                   /evidence="ECO:0000250|UniProtKB:Q07071"
FT   REGION          463..465
FT                   /note="Essential for interaction with GCK"
FT                   /evidence="ECO:0000269|PubMed:23733961"
FT   BINDING         109..110
FT                   /ligand="beta-D-fructose 1-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:138881"
FT                   /evidence="ECO:0000269|PubMed:23621087,
FT                   ECO:0007744|PDB:4BB9"
FT   BINDING         109..110
FT                   /ligand="beta-D-fructose 6-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:57634"
FT                   /evidence="ECO:0000250|UniProtKB:Q07071"
FT   BINDING         153
FT                   /ligand="beta-D-fructose 1-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:138881"
FT                   /evidence="ECO:0000269|PubMed:23621087,
FT                   ECO:0007744|PDB:4BB9"
FT   BINDING         179..181
FT                   /ligand="beta-D-fructose 1-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:138881"
FT                   /evidence="ECO:0000269|PubMed:23621087,
FT                   ECO:0007744|PDB:4BB9"
FT   BINDING         179..181
FT                   /ligand="beta-D-fructose 6-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:57634"
FT                   /evidence="ECO:0000250|UniProtKB:Q07071"
FT   BINDING         348
FT                   /ligand="beta-D-fructose 1-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:138881"
FT                   /evidence="ECO:0000269|PubMed:23621087,
FT                   ECO:0007744|PDB:4BB9"
FT   BINDING         514
FT                   /ligand="beta-D-fructose 1-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:138881"
FT                   /evidence="ECO:0000269|PubMed:23621087,
FT                   ECO:0007744|PDB:4BB9"
FT   BINDING         514
FT                   /ligand="beta-D-fructose 6-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:57634"
FT                   /evidence="ECO:0000250|UniProtKB:Q07071"
FT   VAR_SEQ         144..150
FT                   /note="SVVASRE -> WLPGRRE (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_054853"
FT   VAR_SEQ         151..625
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_054854"
FT   VARIANT         77
FT                   /note="E -> G (in dbSNP:rs8179206)"
FT                   /evidence="ECO:0000269|Ref.3"
FT                   /id="VAR_018849"
FT   VARIANT         256
FT                   /note="G -> S (in dbSNP:rs8179212)"
FT                   /evidence="ECO:0000269|Ref.3"
FT                   /id="VAR_018850"
FT   VARIANT         446
FT                   /note="P -> L (associated with high triglyceride levels and
FT                   low fasting plasma glucose levels; associated with a
FT                   reduced risk for type 2 diabetes; the mutant protein is
FT                   less efficiently regulated by physiological concentrations
FT                   of fructose-6 phosphate; dbSNP:rs1260326)"
FT                   /evidence="ECO:0000269|PubMed:15815621,
FT                   ECO:0000269|PubMed:18556336, ECO:0000269|PubMed:18678614,
FT                   ECO:0000269|PubMed:19643913, ECO:0000269|Ref.3"
FT                   /id="VAR_008906"
FT   VARIANT         540
FT                   /note="R -> Q (in dbSNP:rs8179249)"
FT                   /evidence="ECO:0000269|Ref.3"
FT                   /id="VAR_018851"
FT   MUTAGEN         326..327
FT                   /note="KK->TT: No effect on inhibition of glucokinase."
FT                   /evidence="ECO:0000269|PubMed:23621087"
FT   MUTAGEN         413
FT                   /note="D->A: Impairs inhibition of glucokinase."
FT                   /evidence="ECO:0000269|PubMed:23733961"
FT   MUTAGEN         450..451
FT                   /note="KK->TT: Impairs inhibition of glucokinase."
FT                   /evidence="ECO:0000269|PubMed:23621087"
FT   MUTAGEN         463..465
FT                   /note="LLF->ALA: Abolishes interaction with GCK. Abolishes
FT                   inhibition of GCK."
FT                   /evidence="ECO:0000269|PubMed:23733961"
FT   CONFLICT        251
FT                   /note="P -> V (in Ref. 2; CAB61828)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        393
FT                   /note="L -> P (in Ref. 1; CAA88367)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        560
FT                   /note="H -> R (in Ref. 1; CAA88367)"
FT                   /evidence="ECO:0000305"
FT   TURN            2..4
FT                   /evidence="ECO:0007829|PDB:4PX2"
FT   HELIX           5..7
FT                   /evidence="ECO:0007829|PDB:4PX2"
FT   TURN            19..22
FT                   /evidence="ECO:0007829|PDB:4PX2"
FT   HELIX           23..26
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   HELIX           30..32
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   HELIX           36..38
FT                   /evidence="ECO:0007829|PDB:4PX2"
FT   HELIX           41..43
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   HELIX           46..58
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   HELIX           59..61
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   HELIX           77..94
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   STRAND          100..107
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   HELIX           108..127
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   STRAND          134..138
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   HELIX           143..146
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   HELIX           150..154
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   HELIX           156..167
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   STRAND          171..178
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   HELIX           185..195
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   TURN            198..200
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   STRAND          201..206
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   HELIX           211..213
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   STRAND          222..224
FT                   /evidence="ECO:0007829|PDB:4PX2"
FT   HELIX           226..237
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   TURN            238..240
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   STRAND          243..245
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   TURN            258..260
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   HELIX           261..283
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   HELIX           289..307
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   HELIX           310..325
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   STRAND          330..335
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   HELIX           337..353
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   STRAND          359..366
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   TURN            369..371
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   HELIX           375..377
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   TURN            378..380
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   HELIX           383..385
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   HELIX           389..395
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   HELIX           397..399
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   STRAND          405..411
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   HELIX           416..427
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   STRAND          433..440
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   HELIX           447..452
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   STRAND          453..455
FT                   /evidence="ECO:0007829|PDB:4OP2"
FT   STRAND          457..461
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   TURN            467..469
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   HELIX           470..495
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   TURN            496..498
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   HELIX           513..527
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   HELIX           531..543
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   HELIX           550..553
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   HELIX           557..564
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   STRAND          567..569
FT                   /evidence="ECO:0007829|PDB:4OP3"
FT   HELIX           570..580
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   HELIX           584..592
FT                   /evidence="ECO:0007829|PDB:4BB9"
FT   STRAND          594..596
FT                   /evidence="ECO:0007829|PDB:4BBA"
FT   HELIX           597..605
FT                   /evidence="ECO:0007829|PDB:4BB9"
SQ   SEQUENCE   625 AA;  68685 MW;  DE750462AC603C80 CRC64;
     MPGTKRFQHV IETPEPGKWE LSGYEAAVPI TEKSNPLTQD LDKADAENIV RLLGQCDAEI
     FQEEGQALST YQRLYSESIL TTMVQVAGKV QEVLKEPDGG LVVLSGGGTS GRMAFLMSVS
     FNQLMKGLGQ KPLYTYLIAG GDRSVVASRE GTEDSALHGI EELKKVAAGK KRVIVIGISV
     GLSAPFVAGQ MDCCMNNTAV FLPVLVGFNP VSMARNDPIE DWSSTFRQVA ERMQKMQEKQ
     KAFVLNPAIG PEGLSGSSRM KGGSATKILL ETLLLAAHKT VDQGIAASQR CLLEILRTFE
     RAHQVTYSQS PKIATLMKSV STSLEKKGHV YLVGWQTLGI IAIMDGVECI HTFGADFRDV
     RGFLIGDHSD MFNQKAELTN QGPQFTFSQE DFLTSILPSL TEIDTVVFIF TLDDNLTEVQ
     TIVEQVKEKT NHIQALAHST VGQTLPIPLK KLFPSIISIT WPLLFFEYEG NFIQKFQREL
     STKWVLNTVS TGAHVLLGKI LQNHMLDLRI SNSKLFWRAL AMLQRFSGQS KARCIESLLR
     AIHFPQPLSD DIRAAPISCH VQVAHEKEQV IPIALLSLLF RCSITEAQAH LAAAPSVCEA
     VRSALAGPGQ KRTADPLEIL EPDVQ
//
